ARCHIVES

51% Control Rate Achieved In Phase II Trial of Elderly Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Congress Plans to Accelerate Development of Drugs, Devices

December 19, 2014

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

In Brief; Burkitt, Epstein Will Divide Bristol-Myers Award; “Italian Nobel” Won By Columbia’s Sol Spiegelman

March 26, 1982

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

DT Board Oks RFAs In Surgery, HIV, Breast Cancer

June 18, 1993

In Brief: Survey Finds Most Localities Have Smoking Limits; Martocchio, Rickel ONS Award Speakers

April 24, 1987